Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
Clinical trial NCT05537571 · COMPLETED
Trial details
- NCT number
- NCT05537571
- Sponsor
- Silence Therapeutics plc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2024-01-11
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.